Cargando…

Targeted degradation via direct 26S proteasome recruitment

Engineered destruction of target proteins by recruitment to the cell’s degradation machinery has emerged as a promising strategy in drug discovery. The majority of molecules that facilitate targeted degradation do so via a select number of ubiquitin ligases, restricting this therapeutic approach to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashore, Charlene, Prakash, Sumit, Johnson, Matthew C., Conrad, Ryan J., Kekessie, Ivy A., Scales, Suzie J., Ishisoko, Noriko, Kleinheinz, Tracy, Liu, Peter S., Popovych, Nataliya, Wecksler, Aaron T., Zhou, Lijuan, Tam, Christine, Zilberleyb, Inna, Srinivasan, Rajini, Blake, Robert A., Song, Aimin, Staben, Steven T., Zhang, Yingnan, Arnott, David, Fairbrother, Wayne J., Foster, Scott A., Wertz, Ingrid E., Ciferri, Claudio, Dueber, Erin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797404/
https://www.ncbi.nlm.nih.gov/pubmed/36577875
http://dx.doi.org/10.1038/s41589-022-01218-w
_version_ 1784860679107248128
author Bashore, Charlene
Prakash, Sumit
Johnson, Matthew C.
Conrad, Ryan J.
Kekessie, Ivy A.
Scales, Suzie J.
Ishisoko, Noriko
Kleinheinz, Tracy
Liu, Peter S.
Popovych, Nataliya
Wecksler, Aaron T.
Zhou, Lijuan
Tam, Christine
Zilberleyb, Inna
Srinivasan, Rajini
Blake, Robert A.
Song, Aimin
Staben, Steven T.
Zhang, Yingnan
Arnott, David
Fairbrother, Wayne J.
Foster, Scott A.
Wertz, Ingrid E.
Ciferri, Claudio
Dueber, Erin C.
author_facet Bashore, Charlene
Prakash, Sumit
Johnson, Matthew C.
Conrad, Ryan J.
Kekessie, Ivy A.
Scales, Suzie J.
Ishisoko, Noriko
Kleinheinz, Tracy
Liu, Peter S.
Popovych, Nataliya
Wecksler, Aaron T.
Zhou, Lijuan
Tam, Christine
Zilberleyb, Inna
Srinivasan, Rajini
Blake, Robert A.
Song, Aimin
Staben, Steven T.
Zhang, Yingnan
Arnott, David
Fairbrother, Wayne J.
Foster, Scott A.
Wertz, Ingrid E.
Ciferri, Claudio
Dueber, Erin C.
author_sort Bashore, Charlene
collection PubMed
description Engineered destruction of target proteins by recruitment to the cell’s degradation machinery has emerged as a promising strategy in drug discovery. The majority of molecules that facilitate targeted degradation do so via a select number of ubiquitin ligases, restricting this therapeutic approach to tissue types that express the requisite ligase. Here, we describe a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome. The proteolytic complex is essential and abundantly expressed in all cells; however, proteasomal ligands remain scarce. We identify potent peptidic macrocycles that bind directly to the 26S proteasome subunit PSMD2, with a 2.5-Å-resolution cryo-electron microscopy complex structure revealing a binding site near the 26S pore. Conjugation of this macrocycle to a potent BRD4 ligand enabled generation of chimeric molecules that effectively degrade BRD4 in cells, thus demonstrating that degradation via direct proteasomal recruitment is a viable strategy for targeted protein degradation. [Image: see text]
format Online
Article
Text
id pubmed-9797404
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-97974042022-12-30 Targeted degradation via direct 26S proteasome recruitment Bashore, Charlene Prakash, Sumit Johnson, Matthew C. Conrad, Ryan J. Kekessie, Ivy A. Scales, Suzie J. Ishisoko, Noriko Kleinheinz, Tracy Liu, Peter S. Popovych, Nataliya Wecksler, Aaron T. Zhou, Lijuan Tam, Christine Zilberleyb, Inna Srinivasan, Rajini Blake, Robert A. Song, Aimin Staben, Steven T. Zhang, Yingnan Arnott, David Fairbrother, Wayne J. Foster, Scott A. Wertz, Ingrid E. Ciferri, Claudio Dueber, Erin C. Nat Chem Biol Article Engineered destruction of target proteins by recruitment to the cell’s degradation machinery has emerged as a promising strategy in drug discovery. The majority of molecules that facilitate targeted degradation do so via a select number of ubiquitin ligases, restricting this therapeutic approach to tissue types that express the requisite ligase. Here, we describe a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome. The proteolytic complex is essential and abundantly expressed in all cells; however, proteasomal ligands remain scarce. We identify potent peptidic macrocycles that bind directly to the 26S proteasome subunit PSMD2, with a 2.5-Å-resolution cryo-electron microscopy complex structure revealing a binding site near the 26S pore. Conjugation of this macrocycle to a potent BRD4 ligand enabled generation of chimeric molecules that effectively degrade BRD4 in cells, thus demonstrating that degradation via direct proteasomal recruitment is a viable strategy for targeted protein degradation. [Image: see text] Nature Publishing Group US 2022-12-28 2023 /pmc/articles/PMC9797404/ /pubmed/36577875 http://dx.doi.org/10.1038/s41589-022-01218-w Text en © Genentech, Inc. 2022 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bashore, Charlene
Prakash, Sumit
Johnson, Matthew C.
Conrad, Ryan J.
Kekessie, Ivy A.
Scales, Suzie J.
Ishisoko, Noriko
Kleinheinz, Tracy
Liu, Peter S.
Popovych, Nataliya
Wecksler, Aaron T.
Zhou, Lijuan
Tam, Christine
Zilberleyb, Inna
Srinivasan, Rajini
Blake, Robert A.
Song, Aimin
Staben, Steven T.
Zhang, Yingnan
Arnott, David
Fairbrother, Wayne J.
Foster, Scott A.
Wertz, Ingrid E.
Ciferri, Claudio
Dueber, Erin C.
Targeted degradation via direct 26S proteasome recruitment
title Targeted degradation via direct 26S proteasome recruitment
title_full Targeted degradation via direct 26S proteasome recruitment
title_fullStr Targeted degradation via direct 26S proteasome recruitment
title_full_unstemmed Targeted degradation via direct 26S proteasome recruitment
title_short Targeted degradation via direct 26S proteasome recruitment
title_sort targeted degradation via direct 26s proteasome recruitment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797404/
https://www.ncbi.nlm.nih.gov/pubmed/36577875
http://dx.doi.org/10.1038/s41589-022-01218-w
work_keys_str_mv AT bashorecharlene targeteddegradationviadirect26sproteasomerecruitment
AT prakashsumit targeteddegradationviadirect26sproteasomerecruitment
AT johnsonmatthewc targeteddegradationviadirect26sproteasomerecruitment
AT conradryanj targeteddegradationviadirect26sproteasomerecruitment
AT kekessieivya targeteddegradationviadirect26sproteasomerecruitment
AT scalessuziej targeteddegradationviadirect26sproteasomerecruitment
AT ishisokonoriko targeteddegradationviadirect26sproteasomerecruitment
AT kleinheinztracy targeteddegradationviadirect26sproteasomerecruitment
AT liupeters targeteddegradationviadirect26sproteasomerecruitment
AT popovychnataliya targeteddegradationviadirect26sproteasomerecruitment
AT wecksleraaront targeteddegradationviadirect26sproteasomerecruitment
AT zhoulijuan targeteddegradationviadirect26sproteasomerecruitment
AT tamchristine targeteddegradationviadirect26sproteasomerecruitment
AT zilberleybinna targeteddegradationviadirect26sproteasomerecruitment
AT srinivasanrajini targeteddegradationviadirect26sproteasomerecruitment
AT blakeroberta targeteddegradationviadirect26sproteasomerecruitment
AT songaimin targeteddegradationviadirect26sproteasomerecruitment
AT stabenstevent targeteddegradationviadirect26sproteasomerecruitment
AT zhangyingnan targeteddegradationviadirect26sproteasomerecruitment
AT arnottdavid targeteddegradationviadirect26sproteasomerecruitment
AT fairbrotherwaynej targeteddegradationviadirect26sproteasomerecruitment
AT fosterscotta targeteddegradationviadirect26sproteasomerecruitment
AT wertzingride targeteddegradationviadirect26sproteasomerecruitment
AT ciferriclaudio targeteddegradationviadirect26sproteasomerecruitment
AT duebererinc targeteddegradationviadirect26sproteasomerecruitment